Cargando…

Chronic Myeloid Leukemia: Part I—Real-World Treatment Patterns, Healthcare Resource Utilization, and Associated Costs in Later Lines of Therapy in the United States

Background: Despite advances in tyrosine kinase inhibitor (TKI) therapy for chronic myeloid leukemia in chronic phase (CML-CP), a sizeable proportion of patients with CML-CP remains refractory or intolerant to these agents. Objectives: Treatment patterns, healthcare resource utilization (HRU), and c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Atallah, Ehab L., Maegawa, Rodrigo, Latremouille-Viau, Dominick, Rossi, Carmine, Guérin, Annie, Wu, Eric Q., Patwardhan, Pallavi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Columbia Data Analytics, LLC 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352872/ https://www.ncbi.nlm.nih.gov/pubmed/35979528 http://dx.doi.org/10.36469/001c.36975

Ejemplares similares

Chronic Myeloid Leukemia: Part II—Cost of Care Among Patients in Advanced Phases or Later Lines of Therapy in Chronic Phase in the United States from a Commercial Perspective
por: Atallah, Ehab L., et al.
Publicado: (2022)

Healthcare Resource Utilization and Costs Among Patients With Gastroesophageal Reflux Disease, Barrett’s Esophagus, and Barrett’s Esophagus-Related Neoplasia in the United States
por: Sharma, Prateek, et al.
Publicado: (2023)

Real-world upper endoscopy utilization patterns among patients with gastroesophageal reflux disease, Barrett esophagus, and Barrett esophagus-related esophageal neoplasia in the United States
por: Sharma, Prateek, et al.
Publicado: (2023)

Low-intensity induction in acute myeloid leukemia. Always in the patients' best interest?
por: Atallah, Ehab
Publicado: (2022)

Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: when and for whom?
por: Atallah, Ehab, et al.
Publicado: (2020)

Dasatinib dose management for the treatment of chronic myeloid leukemia
por: Talpaz, Moshe, et al.
Publicado: (2018)

Economic burden of peanut allergy in pediatric patients with evidence of reactions to peanuts in the United States
por: Blaiss, Michael S, et al.
Publicado: (2021)

Characterization of Patients with Ankylosing Spondylitis Receiving Secukinumab and Reasons for Initiating Treatment: A US Physician Survey and Retrospective Medical Chart Review
por: Joshi, Reeti, et al.
Publicado: (2019)

Characteristics of Patients with Psoriatic Arthritis Receiving Secukinumab and Reasons for Initiation: A US Retrospective Medical Chart Review
por: Sunkureddi, Prashanth, et al.
Publicado: (2019)

Disease Burden, Treatment Patterns, and Economic Impact of Rectovaginal Fistulas in Patients with Crohn’s Disease: Findings from a Retrospective, Observational, Longitudinal Study Based on US Claims Databases
por: Karki, Chitra, et al.
Publicado: (2023)

P681: MATCHING-ADJUSTED INDIRECT COMPARISON OF ASCIMINIB VERSUS OTHER TYROSINE KINASE INHIBITORS IN THIRD-OR-LATER LINE CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA
por: Atallah, Ehab, et al.
Publicado: (2023)

Assessing utility values for treatment-related health states of acute myeloid leukemia in the United States
por: Stein, Eytan M., et al.
Publicado: (2018)

Results of treatment of acute myeloid leukemia in central part of Iran
por: Ashrafi, Farzaneh, et al.
Publicado: (2013)

Amebic Encephalitis in a Patient with Chronic Lymphocytic Leukemia on Ibrutinib Therapy
por: Voshtina, Ensi, et al.
Publicado: (2018)

Treatment of Acute Myeloid Leukemia in Older Adults
por: Alsouqi, Aseel, et al.
Publicado: (2023)

Matching-adjusted indirect comparison of asciminib versus other treatments in chronic-phase chronic myeloid leukemia after failure of two prior tyrosine kinase inhibitors
por: Atallah, Ehab, et al.
Publicado: (2023)

Real-World Analysis of the Therapeutic Management and Disease Burden in Chronic Myeloid Leukemia Patients with Later Lines in Italy
por: Breccia, Massimo, et al.
Publicado: (2022)

Calreticulin mediates immune recognition of acute myeloid leukemia cells in vivo
por: Chen, Xiufen, et al.
Publicado: (2013)

Acute myeloid leukemia: negative prognostic impact of early blast persistence can be in part overcome by a later remission prior to post-induction therapy
por: Ihlow, Jana, et al.
Publicado: (2021)

The Economic Burden of Chronic Myeloid Leukemia in Patients with Later Lines: Findings from a Real-World Analysis in Italy
por: Breccia, Massimo, et al.
Publicado: (2022)

Follicular Lymphoma Secondary to Chronic Myeloid Leukemia During Treatment With Imatinib
por: Geelani, Sajad A, et al.
Publicado: (2022)

Modeling of Chronic Myeloid Leukemia: An Overview of In Vivo Murine and Human Xenograft Models
por: Sontakke, Pallavi, et al.
Publicado: (2016)

Patient- and physician-reported pain after tyrosine kinase inhibitor discontinuation among patients with chronic myeloid leukemia
por: Flynn, Kathryn E., et al.
Publicado: (2022)

Novel Approaches to Treatment of Acute Myeloid Leukemia Relapse Post Allogeneic Stem Cell Transplantation
por: Liberatore, Carmine, et al.
Publicado: (2023)

P489: PROGNOSTIC IMPACT OF “MULTI-HIT” VERSUS “SINGLE-HIT” TP53 MUTATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA: RESULTS FROM THE CONSORTIUM ON MYELOID MALIGNANCIES AND NEOPLASTIC DISEASES (COMMAND)
por: Badar, Talha, et al.
Publicado: (2023)

Calreticulin promotes immunity and type I interferon-dependent survival in mice with acute myeloid leukemia
por: Chen, Xiufen, et al.
Publicado: (2017)

Kaposi’s sarcoma associated with chronic myeloid leukemia and imatinib mesylate therapy
por: D’Addona, Matteo, et al.
Publicado: (2022)

Chronic myeloid leukemia versus acute myeloid leukemia in patients with retinoblastoma
por: Leahey, Ann-Marie, et al.
Publicado: (2021)

Economic burden of acute myeloid leukemia on patients in a resource-limited tertiary hospital in the Philippines
por: Catapia, Jean Rachel M., et al.
Publicado: (2023)

Impact of Covid-19 on the treatment of acute myeloid leukemia
por: Ferrara, Felicetto, et al.
Publicado: (2020)

Acute Myeloid Leukemia
Publicado: (2019)

Acute myeloid leukemia
por: Haferlach, Torsten
Publicado: (2019)

Chronic myeloid leukemia
por: Hantschel, Oliver
Publicado: (2019)

Acute myeloid leukemia
por: Ossenkoppele, Gert
Publicado: (2018)

Chronic myeloid leukemia
por: Sauβele, Susanne
Publicado: (2018)

The clinical profile, management, and outcome of febrile neutropenia in acute myeloid leukemia from resource constraint settings
por: Mishra, Kundan, et al.
Publicado: (2021)

Histone chaperone HIRA dictate proliferation vs differentiation of chronic myeloid leukemia cells
por: Majumder, Aditi, et al.
Publicado: (2019)

P688: ASC2ESCALATE: A US PHASE 2, OPEN-LABEL, SINGLE-ARM, DOSE-ESCALATION STUDY OF ASCIMINIB MONOTHERAPY IN 2ND-LINE (2L) TREATMENT OF PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP)
por: Atallah, Ehab, et al.
Publicado: (2023)

Bringing Gene Therapies for HIV Disease to Resource-Limited Parts of the World
por: McCune, Joseph M., et al.
Publicado: (2021)

Myeloid Derived Suppressor Cells in Chronic Myeloid Leukemia
por: Giallongo, Cesarina, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_a62fckji8knvcipb92ufjvjkac